Market Closed -
NSE India S.E.
07:43:54 2024-07-12 am EDT
|
5-day change
|
1st Jan Change
|
161.6
INR
|
+0.08%
|
|
+0.79%
|
+11.28%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
1,103
|
629.7
|
1,533
|
5,061
|
3,322
|
7,194
|
Enterprise Value (EV)
1 |
1,323
|
662.9
|
1,291
|
4,779
|
3,020
|
6,464
|
P/E ratio
|
9.06
x
|
3.44
x
|
6.8
x
|
15.4
x
|
8.48
x
|
11.3
x
|
Yield
|
2.67%
|
-
|
-
|
-
|
2.21%
|
1.43%
|
Capitalization / Revenue
|
0.37
x
|
0.23
x
|
0.67
x
|
1.33
x
|
0.69
x
|
1.19
x
|
EV / Revenue
|
0.44
x
|
0.24
x
|
0.56
x
|
1.25
x
|
0.63
x
|
1.07
x
|
EV / EBITDA
|
5.75
x
|
2.3
x
|
3.69
x
|
9.37
x
|
5.19
x
|
6.61
x
|
EV / FCF
|
9
x
|
3.73
x
|
5.67
x
|
-2,673
x
|
-41
x
|
12.7
x
|
FCF Yield
|
11.1%
|
26.8%
|
17.6%
|
-0.04%
|
-2.44%
|
7.88%
|
Price to Book
|
1.29
x
|
0.63
x
|
1.25
x
|
3.25
x
|
1.73
x
|
2.92
x
|
Nbr of stocks (in thousands)
|
58,846
|
58,846
|
58,846
|
58,846
|
58,846
|
58,846
|
Reference price
2 |
18.75
|
10.70
|
26.05
|
86.00
|
56.45
|
122.2
|
Announcement Date
|
7/8/19
|
7/19/20
|
7/13/21
|
7/7/22
|
5/26/23
|
7/2/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
2,998
|
2,732
|
2,289
|
3,815
|
4,821
|
6,031
|
EBITDA
1 |
230.2
|
287.6
|
349.8
|
510.1
|
581.7
|
978.2
|
EBIT
1 |
185
|
239.7
|
303.4
|
463.6
|
524.7
|
907.2
|
Operating Margin
|
6.17%
|
8.78%
|
13.25%
|
12.15%
|
10.88%
|
15.04%
|
Earnings before Tax (EBT)
1 |
159.6
|
243.5
|
314.8
|
460.7
|
552.1
|
950.8
|
Net income
1 |
121.9
|
183.3
|
225.4
|
328.9
|
391.8
|
637.8
|
Net margin
|
4.06%
|
6.71%
|
9.85%
|
8.62%
|
8.13%
|
10.58%
|
EPS
2 |
2.070
|
3.110
|
3.830
|
5.588
|
6.657
|
10.84
|
Free Cash Flow
1 |
147
|
177.7
|
227.7
|
-1.788
|
-73.64
|
509.3
|
FCF margin
|
4.9%
|
6.51%
|
9.95%
|
-0.05%
|
-1.53%
|
8.44%
|
FCF Conversion (EBITDA)
|
63.86%
|
61.78%
|
65.1%
|
-
|
-
|
52.06%
|
FCF Conversion (Net income)
|
120.66%
|
96.94%
|
101%
|
-
|
-
|
79.85%
|
Dividend per Share
2 |
0.5000
|
-
|
-
|
-
|
1.250
|
1.750
|
Announcement Date
|
7/8/19
|
7/19/20
|
7/13/21
|
7/7/22
|
5/26/23
|
7/2/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
220
|
33.3
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
242
|
282
|
302
|
730
|
Leverage (Debt/EBITDA)
|
0.9544
x
|
0.1157
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
147
|
178
|
228
|
-1.79
|
-73.6
|
509
|
ROE (net income / shareholders' equity)
|
14.9%
|
19.7%
|
20.2%
|
23.6%
|
22.5%
|
29.1%
|
ROA (Net income/ Total Assets)
|
7.88%
|
10.1%
|
12%
|
14.7%
|
13.3%
|
19.2%
|
Assets
1 |
1,546
|
1,809
|
1,882
|
2,234
|
2,947
|
3,315
|
Book Value Per Share
2 |
14.50
|
17.00
|
20.90
|
26.50
|
32.60
|
41.90
|
Cash Flow per Share
2 |
0.9300
|
0.0600
|
2.170
|
1.170
|
2.000
|
1.000
|
Capex
1 |
95.2
|
25.5
|
51
|
205
|
205
|
156
|
Capex / Sales
|
3.17%
|
0.93%
|
2.23%
|
5.36%
|
4.24%
|
2.58%
|
Announcement Date
|
7/8/19
|
7/19/20
|
7/13/21
|
7/7/22
|
5/26/23
|
7/2/24
|
|
1st Jan change
|
Capi.
|
---|
| +11.28% | 114M | | +3.74% | 104B | | -10.18% | 59.99B | | +80.95% | 50.92B | | +8.46% | 36.09B | | -0.02% | 30.95B | | +4.78% | 18.85B | | +18.14% | 17.61B | | +9.26% | 13.97B | | +78.32% | 13B |
Other Commodity Chemicals
|